| Business Summary | | Donlar
Biosyntrex
Corporation,
formerly
Biomune
Systems,
Inc.,
is
a
diverse
biotech
and
biopolymer
company
specializing
in
the
development,
manufacture,
marketing
and
sales
of
both
synthetic
and
natural
protein
technologies.
These
protein
products
are
used
in
a
global
range
of
industrial,
agricultural,
nutraceutical
and
consumer
markets.
The
synthetic
proteins
are
a
new
family
of
biopolymers,
known
as
thermal
polyaspartates,
that
are
non-hazardous,
non-toxic,
hypoallergenic,
environmentally
friendly
and
biodegradable.
The
natural
proteins
are
produced
from
milk
by-products
(whey)
and
contain
high
levels
of
immunoglobulins
(antibodies)
useful
in
pharmaceutical,
nutrient
supplement
and
nutraceutical
applications.
The
Company
operates
through
three
business
segments,
BioPolymers
(Industrial
Products),
AgriSciences
(Agriculture)
and
Optim
Nutrition
(Nutraceuticals).
Donlar
Biosyntrex
was
formed
through
a
reverse
acquisition
between
Biomune
Systems
and
Donlar
Corporation
in
January
2001. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Donlar
Biosyntrex
Corporation
conducts
business
through
three
business
segments:
BioPolymers
(performance
chemicals
business),
AgriSciencies
(agricultural
business),
and
Optim
Nutrition
(biomune
nutritional
and
nutraceuticals
business).
For
the
six
months
ended
6/30/01,
revenues
totalled
$1.2
million,
up
from
$583
thousand.
Net
loss
applicable
to
Common
rose
59%
to
$8.7
million.
Results
reflect
growth
in
the
BioPolymer
segment
sales,
offset
by
higher
warrant
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Larry Koskan, 58 Chairman,
Pres, CEO | $31K | Robert Pietrangelo, 60 COO | -- | Joseph Prochaska, 55 VP | -- | Joel Lurquin, 35 Controller,
Treasurer, Acting Sec. | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|